Literature DB >> 12473473

A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit.

C Dupeyron1, B Campillo, M Bordes, E Faubert, J-P Richardet, N Mangeney.   

Abstract

We assessed the incidence of nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) on admission, the rate of acquisition during the hospital stay and the relationship with subsequent infection in a digestive disease unit. The efficacy of a program of nasal carriage eradication with mupirocin was evaluated simultaneously. Over one year 484 patients were studied prospectively on admission for nasal and stool carriage of MRSA, then every week for nasal carriage. Nearly 70% (68.8%) of patients had chronic liver diseases. Nasal carriers were assigned to a five-day course of intranasal mupirocin ointment. One hundred and seventeen (24.2%) patients were MRSA positive, 57 (11.8%) of which were carriers on admission and 60 (12.4%) acquired carriage. Of these, 86 were treated with mupirocin with a success rate of 98.8% and 25.9% of them recolonized. Fourteen patients were retreated, to allow eradication in 71.4% of cases. Seventy percent of these became carriers again. One high-level mupirocin-resistant strain was isolated before treatment and seven during or after treatment. Hospital stay and stool carriage were independently associated with reacquisition (P = 0.0105 and P = 0.0462, respectively). Molecular analysis showed identity between the strains isolated from infection samples and from nasal swabs during the same week. For every patient who became recolonized, nasal strains isolated before and after eradication were the same in 70% of cases. Mortality during hospital stay was independently associated with age (P = 0.0081), MRSA nasal carriage (P = 0.02631), MRSA infection (P < 0.0001) and liver disease (P = 0.0017). This study did not show a change in the prevalence rate of infection in the unit during treatment with mupirocin. This treatment should only be attempted once due to the risk of emergence of high-level resistant strains. Copyright 2002 The Hospital Infection Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473473     DOI: 10.1053/jhin.2002.1287

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  Successful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-up.

Authors:  F P N Mollema; J A Severin; J L Nouwen; A Ott; H A Verbrugh; M C Vos
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

Review 2.  Control of methicillin-resistant Staphylococcus aureus in the UK.

Authors:  I M Gould
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

Review 3.  Staphylococcal skin infections in children: rational drug therapy recommendations.

Authors:  Shamez Ladhani; Mehdi Garbash
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 4.  Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?

Authors:  D S Acton; M J Tempelmans Plat-Sinnige; W van Wamel; N de Groot; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-08       Impact factor: 3.267

Review 5.  Fecal Carriage of Staphylococcus aureus in the Hospital and Community Setting: A Systematic Review.

Authors:  Shantelle Claassen-Weitz; Adebayo O Shittu; Michelle R Ngwarai; Lehana Thabane; Mark P Nicol; Mamadou Kaba
Journal:  Front Microbiol       Date:  2016-05-10       Impact factor: 5.640

6.  The Stealthy Superbug: the Role of Asymptomatic Enteric Carriage in Maintaining a Long-Term Hospital Outbreak of ST228 Methicillin-Resistant Staphylococcus aureus.

Authors:  Laurence Senn; Olivier Clerc; Giorgio Zanetti; Patrick Basset; Guy Prod'hom; Nicola C Gordon; Anna E Sheppard; Derrick W Crook; Richard James; Harry A Thorpe; Edward J Feil; Dominique S Blanc
Journal:  mBio       Date:  2016-01-19       Impact factor: 7.867

7.  Beyond the Intensive Care Unit (ICU): Countywide Impact of Universal ICU Staphylococcus aureus Decolonization.

Authors:  Bruce Y Lee; Sarah M Bartsch; Kim F Wong; James A McKinnell; Eric Cui; Chenghua Cao; Diane S Kim; Loren G Miller; Susan S Huang
Journal:  Am J Epidemiol       Date:  2016-02-11       Impact factor: 4.897

8.  The role of Staphylococcus aureus carriage in the pathogenesis of bloodstream infection.

Authors:  Caroline Marshall; Emma McBryde
Journal:  BMC Res Notes       Date:  2014-07-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.